AR092570A1 - ORAL COMPOSITION CONTAINING DAPOXETINE AS A FREE BASE - Google Patents

ORAL COMPOSITION CONTAINING DAPOXETINE AS A FREE BASE

Info

Publication number
AR092570A1
AR092570A1 ARP130103296A ARP130103296A AR092570A1 AR 092570 A1 AR092570 A1 AR 092570A1 AR P130103296 A ARP130103296 A AR P130103296A AR P130103296 A ARP130103296 A AR P130103296A AR 092570 A1 AR092570 A1 AR 092570A1
Authority
AR
Argentina
Prior art keywords
free base
composition containing
oral composition
dapoxetine
containing dapoxetine
Prior art date
Application number
ARP130103296A
Other languages
Spanish (es)
Inventor
Jeon Hong
Ryeol - Cha Bong
Geun - Kim Jun
Ki - Park Su
Jun - Lee Bong-Sang
Original Assignee
Ctc Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ctc Bio Inc filed Critical Ctc Bio Inc
Publication of AR092570A1 publication Critical patent/AR092570A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una forma farmacéutica que se administra disolviendo o desintegrando por vía oral, especialmente aquella en forma de film, que se caracteriza por sus componentes válidos de dapoxetina como base libre y que contiene dapoxetina o sal farmacéuticamente aceptable de la misma.A pharmaceutical form that is administered by dissolving or disintegrating orally, especially that in the form of a film, characterized by its valid components of dapoxetine as a free base and containing dapoxetine or pharmaceutically acceptable salt thereof.

ARP130103296A 2012-09-13 2013-09-13 ORAL COMPOSITION CONTAINING DAPOXETINE AS A FREE BASE AR092570A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20120101772 2012-09-13

Publications (1)

Publication Number Publication Date
AR092570A1 true AR092570A1 (en) 2015-04-22

Family

ID=50278454

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103296A AR092570A1 (en) 2012-09-13 2013-09-13 ORAL COMPOSITION CONTAINING DAPOXETINE AS A FREE BASE

Country Status (3)

Country Link
AR (1) AR092570A1 (en)
TW (1) TW201422224A (en)
WO (1) WO2014042416A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60026146T2 (en) * 1999-09-03 2006-08-17 Apbi Holdings, Llc Use of dapoxetine, A selective serotonin uptake inhibitor, for the treatment of sexual dysfunction
WO2008035358A2 (en) * 2006-06-05 2008-03-27 Cadila Healthcare Limited Process for preparing dapoxetine
EP2056811B8 (en) * 2006-08-14 2018-03-21 Neurohealing Pharmaceuticals, Inc. Modafinil-based treatment for premature ejaculation
KR20120068678A (en) * 2010-09-17 2012-06-27 에스케이케미칼주식회사 (s)-n,n-dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine derivatives, pharmaceutical compositions containing them, and manufacturing methods thereof
WO2012053006A2 (en) * 2010-10-18 2012-04-26 Panacea Biotec Ltd Improved oral fast dissolving films comprising combination of polymers and method of preparation thereof

Also Published As

Publication number Publication date
WO2014042416A1 (en) 2014-03-20
TW201422224A (en) 2014-06-16

Similar Documents

Publication Publication Date Title
CY1121712T1 (en) PLATELET WASTE LAUGHTER
CL2018001199A1 (en) Comprimido de tres capas que comprende un compuesto de formula i, tenofovir alafenamida y emtricitabina; su uso en el tratamiento de una infeccion por vih.
FR2959935B1 (en) ALCOHOL-RESISTANT ORAL PHARMACEUTICAL FORM
GT201500053A (en) PHARMACEUTICAL COMPOSITION COVERED WITH REGORAFENIB
JP2013014622A5 (en)
CL2014001585A1 (en) Betulin derived compounds; pharmaceutical composition; and their use in the treatment and prevention of a hiv infection.
IT1400982B1 (en) TRANS-EPITHELIAL OSMOTIC COLLIRIUM FOR THE CARE OF THE KERATOCONO.
GT201400012A (en) INHIBITOR COMPOUND OF THE SIGNALING OF THE NOTCH TRAJECTORY
GT201200284A (en) PHARMACEUTICAL COMPOSITION
CL2014001016A1 (en) Condensed tricyclic compounds and their pharmaceutically acceptable salts; pharmaceutical composition that includes them; and its use in the treatment of a viral infection.
PE20140255A1 (en) DISPERSIBLE TABLET IN ORAL FORM
CO6801754A2 (en) A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide
GT201200304A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE HYDROMORPHONE AND NALOXONE
EA201171497A1 (en) REDUCTION OF OPIOID FLUCTUATIONS IN THE BLOOD
CO6920289A2 (en) Topical ophthalmic pharmaceutical composition containing regorafenib.
EA201200485A1 (en) ORAL FALLING PHARMACEUTICAL DRUG FORM CONTAINING AIPIPRAZOL
ECSP15030460A (en) LONG-RELEASE DIFENIDOL COMPOSITION
AR087787A1 (en) BENZOTIAZOLONA COMPOSITE
CL2014003484A1 (en) Use of nalmefene in reducing alcohol consumption in a patient with alcohol dependence; oral pharmaceutical composition; pharmaceutical combination.
PE20151282A1 (en) COMBINATION OF MEDICINES INCLUDING PHENYLPHRINE AND PARACETAMOL
UY33789A (en) COMBINATION THAT INCLUDES A FAMILY DERIVATIVE OF COMBRETASTATINAS AND CETUXIMAB
AR092570A1 (en) ORAL COMPOSITION CONTAINING DAPOXETINE AS A FREE BASE
CL2008003711A1 (en) Process for preparing a pharmaceutical dosage form comprising florfenicol or an analog thereof; and to recover florfenicol or an analog of a pharmaceutical composition.
CL2014002203A1 (en) Use of modafinil in the treatment of ***e substitution; Oral pharmaceutical composition containing Modafinil in the form of its dextrogiro enantiomer.
EA201590732A1 (en) DISPENSABLE TABLET

Legal Events

Date Code Title Description
FB Suspension of granting procedure